Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation. Read more about Maintenance immunosuppression with prednisone and RS-61443 alone following liver transplantation.
Immunosuppression and rejection in liver transplantation. Read more about Immunosuppression and rejection in liver transplantation.
Hepatitis C and B in liver transplantation. Read more about Hepatitis C and B in liver transplantation.
Long-term functional xenograft tolerance after intrathymic islet transplantation (Lewis rat-->B6 mouse). Read more about Long-term functional xenograft tolerance after intrathymic islet transplantation (Lewis rat-->B6 mouse).
Immunosuppressive effects of anti-CD3 MAb and soluble co-stimulatory molecules. Read more about Immunosuppressive effects of anti-CD3 MAb and soluble co-stimulatory molecules.
Prolonged survival of rat cardiac allografts after intrathymic inoculation of donor thymocytes. Read more about Prolonged survival of rat cardiac allografts after intrathymic inoculation of donor thymocytes.
Intrathymic inoculation of islets at birth prevents autoimmune diabetes and pancreatic insulitis in the BB rat. Read more about Intrathymic inoculation of islets at birth prevents autoimmune diabetes and pancreatic insulitis in the BB rat.
Intrathymic inoculation of donor cells promotes survival of rat orthotopic liver allografts. Read more about Intrathymic inoculation of donor cells promotes survival of rat orthotopic liver allografts.
Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group. Read more about Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. US Multicenter FK 506 Liver Study Group.
Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group. Read more about Use of FK 506 for the prevention of recurrent allograft rejection after successful conversion from cyclosporine for refractory rejection. US Multicenter FK 506 Liver Study Group.
